Why we're the Leaders in Clinical Research

OMEGA Research Group is a Premier Research Organization, headquartered in Debary, FL. Our consortium of research sites allow us the unique opportunity to conduct clinical trials in all therapeutic areas, while still maintaining that personal touch that is often missing in large corporations. From the initial contact to site close out, we are committed to providing outstanding service that delivers timely and accurate data, well-qualified participants, high retention rates and personalized attention to ensure the success of the trial.

Adherence and compliance with international standards of Good Clinical Practice (GCP) and International Conference of Harmonization (ICH) are the foundation of our quality systems.

Our Network of Providers

OMEGA Research Group contracts with many local practitioners well known for their practices in endocrinology, nephrology, gynecology, rheumatology and internal medicine, to name just a few. 

 

We are supported by a close team of doctors, nurses and other health professionals who take pride in making each interaction positive, every single time. Our research sites are patient centric and are structured to ensure a memorable research experience for our patients, colleagues, and professional associates.

 

We offer generous monitoring space, copy and fax capabilities, as well as complimentary Wi-Fi.

Quick Facts

OMEGA Research Group
OMEGA Research Group

OMEGA Research Group has dedicated site staff that includes, full-time Regulatory Specialists, a Budget/Contract department, Advanced Registered Nurse Practitioners, Physician Assistants, ACLS Certified Registered Nurses, Licensed Practical Nurses, Medical Assistants, and Quality Assurance Specialists.

Established 2006​

Lost to follow up rate less than 2% due to rigorous prescreen methods

Over 200 years of combined research experience​

 Experience in conducting Phase I through Phase IV trials

Dedicated Phase I site able to accommodate up to 24 subjects at one time

Database between 

15,000 - 20,000 active patients